Additionally, we found that the actively treated CLL group exhibited higher levels of cytotoxic cells (including CD8+ T cells and NK cells) when compared to the W&W or the healthy population groups. The gene discussed is CD8A; the disease is B-cell chronic lymphocytic leukemia.